Teofili, Luciana http://orcid.org/0000-0002-7214-1561
Landolfi, Raffaele
Cingolani, Antonella
Antinori, Andrea
Vecchiet, Jacopo
Sanguinetti, Maurizio
Gasbarrini, Antonio
Pasciuto, Tina
Orlando, Nicoletta
Lamonica, Silvia
Article History
Received: 13 October 2020
Accepted: 16 October 2020
First Online: 22 October 2020
Ethics approval and consent to participate
: The ethics committee of Fondazione Policlinico A. Gemelli IRCCS approved the study (Prot. N. 0020131/20, May 13, 2020). We certify that this trial has received ethical approval from the appropriate ethical committee as described above. The participants will be adequately informed in clear, simple and understandable words of the technical terms used and will be invited to provide oral or written informed consent. The participants will be provided with a description of the general aims of the research, the methodology and procedures used, the indication of any benefits or possible risks and adverse effects. In addition to consent to participate in the study, all patients should give consent to receive blood products. The consent can be expressed orally if two different witnesses state that the patient was properly informed and fully understood study aim and procedures, and sign the consent.
: Not applicable
: The authors declare that they have no competing interests.